Interact to see
Advertisement
Advertisement
CURE vs SSO
CURE vs SSO Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SSO commentary
Sep 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and SSO is a StrongBuy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SSO has more net assets: 7.2B vs. CURE (167M). SSO has a higher annual dividend yield than CURE: SSO (14.896) vs CURE (-11.125). CURE was incepted earlier than SSO: CURE (14 years) vs SSO (19 years). SSO (0.89) and CURE (0.93) have comparable expense ratios . CURE has a higher turnover SSO (4.00) vs SSO (4.00).
| CURE | SSO | CURE / SSO | |
| Gain YTD | -11.125 | 14.896 | -75% |
| Net Assets | 167M | 7.2B | 2% |
| Total Expense Ratio | 0.93 | 0.89 | 104% |
| Turnover | 23.00 | 4.00 | 575% |
| Yield | 1.36 | 0.75 | 181% |
| Fund Existence | 14 years | 19 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SSO | |
|---|---|---|
| RSI ODDS (%) | N/A | 6 days ago 88% |
| Stochastic ODDS (%) | 4 days ago 85% | 4 days ago 84% |
| Momentum ODDS (%) | 4 days ago 83% | 4 days ago 90% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 83% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 84% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | 4 days ago 90% | 5 days ago 90% |
| Declines ODDS (%) | 12 days ago 90% | 7 days ago 84% |
| BollingerBands ODDS (%) | 7 days ago 90% | N/A |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MKVHX | 16.73 | 0.08 | +0.48% |
| MFS International Large Cap Value R6 | |||
| ISGNX | 16.75 | 0.05 | +0.30% |
| Columbia Integrated Small Cap Gr Instl | |||
| RIVRX | 36.29 | -0.02 | -0.06% |
| Riverbridge Growth Investor | |||
| AUIIX | 35.66 | -0.11 | -0.31% |
| AB Equity Income I | |||
| FSENX | 59.87 | -1.15 | -1.88% |
| Fidelity Select Energy Portfolio | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +0.93% | ||
| TMO - CURE | 69% Closely correlated | +0.64% | ||
| DHR - CURE | 65% Loosely correlated | +0.59% | ||
| MTD - CURE | 65% Loosely correlated | +1.39% | ||
| RVTY - CURE | 64% Loosely correlated | +1.10% | ||
| A - CURE | 64% Loosely correlated | +0.21% | ||
More | ||||